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INTRODUCTION
“May no living being suffer from pain”
-Lord Buddha.
I start my study with homage to this noble sentiment.
The severity of labor pain was recognized by the Romans, who termed delivery the  poena 
magna—the  “great  pain”  or  “great  punishment.”  Pregnancy,  though  is  one  of  the  most 
pleasant part of a woman’s life is marred by the anxious awaiting of a painful labour. Although 
labor is painless in a few women, the vast majority considers it painful, and a clear majority 
rates  it  as  severe  pain.  Melzack,  one  of  the  authors  of  the  gate  control  theory of  pain, 
developed a questionnaire to assess the intensity and emotional impact of pain. Using this 
tool, he observed that labor pain was rated as more painful than cancer pain and that, among 
nulliparous women with no prepared childbirth training, it was nearly as painful as amputation 
of a digit without anesthesia.
IASP defines  pain  as  “an  unpleasant  sensory and  emotional  experience  associated  with 
actual or potential tissue damage or described in terms of the actual damage.” 
This definition embraces various concepts especially the subjectivity of the symptoms which 
is the basis of the non-pharmacological options in the treatment of labor pain.
AIM:
• To compare Entonox with Epidural Technique ( 0.125 % Bupivacaine with 2 μgm/ml 
Fentanyl) for labour analgesia in
Effectiveness of pain relief
Duration of Labour
Foetal outcome
• To study the influence on maternal and foetal parameters.
HISTORICAL PERSPECTIVES
Ancient methods of pain relief included various plant-derived sedatives,
acupuncture and physical methods such as binding.
In 1842 Crawford long -administered Chloroform anaesthesia
In 1847 James Young Simpson -administered the first obstetric general anaesthetic 
using ether.
In 1853 John Snow -delivered Queen Victoria's eighth child under chloroform.
In 1881 Stanislav Klikovitch- described the use of nitrous oxide for labour in Russia.
In 1902 Morphine and hyoscine was first used in labour.
In 1926  Gelert –administered Para-cervical block for labor pain relief.
In 1927 Della Paine -First lumbar sympathetic block for labor pain relief
In 1928 Cleland - Defined uterine pain pathway
In 1931 Eugen Bogdan Aburel, Romanian obstetrician, described continuous caudal 
plus lumbo aortic plexus blocks in Labour.
In 1935 Graffignere- Epidural block for labor analgesia.
In 1949 Flower First use of continuous epidural block for obstetric analgesia
In 1949 Cleland described continuous lumbar epidural block in labour.
In 1950 Bromage  brought  an  Extensive  and  improved  understanding  to   epidural 
blockade
In 1958 Ferdinand Lamaze published his book suggesting that pain was a conditioned 
reflex  triggered  by  uterine  contractions,  and  that  psycho  prophylaxis  could 
reduce pain.
Further, advancements were made in the fields of labor analgesia to minimize the adverse 
effects of technique and drugs on the mother, foetus, and the labor process. This led to the 
following advancement
1. use of lower concentrations of the drugs
2. Use of continuous infusions of low concentrations
3. Use of Patient Controlled Analgesia technique
4. Limiting analgesia from
a. T10 to L1 – First stage
b. Sacral segments – Second stage
5. Use of Opioids combined with local anesthetic to enhance the analgesic properties.
LABOR PAIN - INCIDENCE AND ITS NEURO ANATOMY
PAIN  IN THE FIRST STAGE OF LABOUR  
Uterine contractions cause stretching,  tearing and distortion and possibly Ischemia of  the 
uterine tissues, whilst simultaneous dilatation of the cervix and stretching of the lower uterine 
segment is occurring. The intensity of the pain increases progressively with the rising strength 
of the  contractions and these painful stimuli are transmitted by A δ and C afferent fibers 
which  accompany sympathetic  pathways  through the  pelvic,  inferior,  middle  and superior 
hypogastric plexuses, the lumbar sympathetic chain, the white rami of the spinal nerves T10, 
T1l, TI2 and LI and the posterior roots of these nerves to reach the spinal cord . In early 
labour, only the nerve roots of TI I and T12are involved, but as the intensity of contractions 
increases, TIO and LI are also recruited.
Clinical Implications—During the first stage of labour, an epidural block limited to the TII, TI 
2 segments at the beginning and later extending to involve TlO and LI will be usually sufficient 
to  provide  excellent  pain  relief  while  avoiding  neural  blockade  of  the  sacral  segments. 
Premature sacral blockade can result in the Ioss of the stimulating effect upon contractions of 
Ferguson’s reflex and the loss of pelvic muscle tone which aids the rotation of the presenting 
part.
PAIN IN THE SECOND STAGE OF LABOUR
The pain caused by distension of the pelvic structure and perineum following descent of the 
presenting part is added to the pain of uterine contractions although, once cervical dilatation 
is complete, the pain induced by contractions may become less intense. The uterine pain 
continues to be referred to TlO—Ll, while the pain produced by stretching or pressure exerted 
on intrapelvic structures, including the peritoneum, bladder, urethra and rectum is referred to 
sacral segments .Pressure on the roots of the lumbosacral plexus may manifest itself as pain 
felt low in the back or in the thighs. Pain produced by stretching the perineum is transmitted 
by the pudendal nerve (S2, 3, 4) and in part by the posterior cutaneous nerve of the thigh (S2, 
3), the genitofemoral nerve (LI, 2) and theilio-inguinal nerve (LI).
Clinical Implications: Later in the first stage and during the earlier part of the second stage, 
pain is often experienced in lower lumbar and upper sacral segments; so the block will have 
to be extended if analgesia is to be guaranteed. Complete block of the sacral segments need 
only be performed when perineal pain become worrisome and, by this stage, the block of the 
thoracolumbar segments will hopefully be decaying to such an extent that abdominal  muscle 
strength will be adequate to permit voluntary expulsive efforts by the mother.
PAIN IN LABOUR: PATHWAYS AND MECHANISMS
Site of Origin Mechanism Pathway Site of Pain
Uterus and Cervix Distortion, 
stretching, tearing 
of fibres
Afferents which 
accompany 
sympathetic 
pathway to T10, TI 
I, Tl2 and LI
Dorsal rami T10—
LI referred to 
cutaneous 
branches of 
posterior divisions
upper abdomen 
and groin’
mid back
Periuterine 
Tissues & 
Lumbosacral 
region
Pressure often in 
association with 
fetal malposition 
or platypelloid 
pelvis
Lumbosacral 
plexus L5, SI (? 
Pelvic splanchnic 
nerves)
low-back, thigh
Bladder ,Urethra, 
Rectum
Pressure by 
presenting part
S 2 ,3,4 referred to 
perineum and 
sacral area
Vagina Distension, tearing Somatic S2,3,4 Not referred
Perineum Distension, tearing Pudendal(S 2, 3, 4) 
Genitofemoral (LI, 
2) 
Ileoinguinal  LI 
Posterior 
cutaneous 
Nerve of thigh, S2, 
3
Not referred
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BLOOD FLOW
MATERNAL AND FETAL CONSEQUENSES OF UNRELIEVED 
PAIN IN LABOUR
THE STRESS RESPONSE TO PAIN IN LABOUR
Segmental  and  supra-segmental  reflex-responses  from  the  pain  of  labour  may  affect 
respiratory, cardiovascular, gastro-intestinal, urinary and neuro-endocrine functions.
Respiratory -  Pain  in  labour  initiates  hyperventilation  leading  to  maternal  hypocarbia, 
respiratory  alkalosis  and  subsequent  compensatory  metabolic  acidosis.  The  oxygen 
dissociation curve is shifted to  the left  and thus reduces tissue oxygen transfer,  which is 
already compromised by the increased oxygen consumption associated with labour.
Cardiovascular -  Labour  results  in  a  progressive  increase  in  maternal  cardiac  output, 
primarily due to an increase in stroke volume, and, to a lesser extent, maternal heart rate. The 
greatest  increase in  cardiac  output  occurs  immediately  after  delivery,  from the  increased 
venous  return  associated  with  relief  of  enocaval  compression  and  the  auto  transfusion 
resulting from uterine involution.
Hormonal - Stimulation of pain results in the release of beta-endorphin and  ACTH from the 
anterior  pituitary.  Associated  anxiety  also  initiates  further  pituitary  response.  Pain  also 
stimulates  the  increased  release  of  both  adrenaline  and  noradrenaline  from  the  adrenal 
medulla which may lead to a progressive rise in peripheral resistance and cardiac output. 
Excessive, sympathetic activity may result in in coordinate uterine action, prolonged labour 
and  abnormal  fetal  heart-rate  patterns.  Activation  of  the  autonomic  nervous  system also 
delays gastric emptying and reduces intestinal peristalsis.
Metabolic -  Maternal:  During  labour,  glucagon,  growth  hormone,  renin  and  ADH  level 
increases while  insulin  and testosterone level  decreases.  Circulating  free  fatty  acids  and 
lactate also increase with a peak level at the time of delivery.
Fetal   :  Maternal catecholamines secreted as a result of labour pain may cause fetal acidosis 
due to low placental blood flow.
METHODS OF PAIN MEASUREMENT
As described earlier pain is a subjective feeling or experience that is influenced by factors like 
cultural learning , the situation, attention and other psychological variables .Most accepted 
version of pain is the three dimensional view of sensory-discriminative ,motivational-affective, 
cognitive-evaluative components.
Methods of pain assessment
1. Verbal numeric rating scale
2. Visual analog scale
3. McGill pain questionnaire
4. Descriptor – Differential scale
VISUAL ANALOG SCALE
Advantages:
• Widely used
• Simple, efficient, minimally intrusive measure of pain intensity.
• Exhibits ratio scale property
• Its conceptual simplicity provided that adequate clear instructions are given to the 
patients.
Disadvantages
• Pain is an uni-dimensinal experience when measured by it
• Bias of expectancy for change and reliance on memory
In this study VAS score of 0 indicates no pain and a VAS score of 100 indicated 
maximum pain.
METHODS OF LABOR PAIN RELIEF
There have been many approaches to the relief of pain in labour throughout history up to the 
present time. The requirements of satisfactory analgesic technique in labour may be listed as 
follows
1. Safety 
2. Effective analgesia throughout painful periods of labour 
3. No depressant effect on the maternal respiratory or cardiovascular system 
4. No depressant effects on the progress of labour 
5. No depressant effects on the baby before or after delivery 
6. No unpleasant maternal side-effects 
7. High technical success rate.
Unfortunately no one technique has all these properties
NON PHARMACOLOGICAL METHODS
Methods of psychological analgesia can be divided into three broad categories :
• Natural child birth - the Read method.
• Psychoprophylaxis - the Lamaze technique.
• Hypnosis
Each technique claims the elimination of pain without any harm to the  mother, the baby or to 
the progress of labour and without the need for chemical analgesia.  All  require adequate 
antenatal  preparation.  Still  most  women  experience  severe  labour  pain.  Furthermore, 
psychological analgesia can place increased demand on the staff.
Support during labour:
A friendly atmosphere in the labour room is preferable to help a woman to cope with  pain. 
Homely surroundings help to allay anxiety and reduce the need for pharmacological 
analgesia.
TENS(trans cutaneous electrical nerve stimulation) ( 10)
TENS was introduced to relieve pain in childbirth in the early 1980s. Since  then the use of 
TENS in labour has become increasingly popular as it is simple to use 
and is non-invasive. The mode of action depends on the two principal theories. One that A-
fibres  are  stimulated  by  the  electrical  stimulation  preventing  the  transmission  of  afferent 
noxious stimulus originating from C-fibres,  the other  that  the electrical  stimulus increases 
endorphins  and  enkephalins  within  the  system.  TENS  electrodes  are  applied  over  the 
dermatomes  supplied  by  T10  to  L1.  The  TENS  machine  then  gives  a  low  background 
stimulus which can be augmented at the time of each contraction. It has been observed in 
clinical  practice that TENS may provide limited pain relief during the first  stage of labour. 
Meta-analysis of randomized controlled trials of TENS in labour does not, however, confirm its 
efficacy
SYSTEMIC
Opioids have been used for anaesthesia in labour for hundreds of years. However, it was not 
until the early twentieth century that techniques deliberately employing the analgesic effects 
of the opioids gained major attention. Unfortunately, dosage and effect are limited by maternal 
and neonatal  side-effects,  so that only moderate pain relief  could be obtained with  these 
drugs.eg..
Pethidine
Buprenorphine 
Nalbuphine.
Tramadol.
Butorphanol 
Fentanyl primarily  acts  on  (MOP)mu-receptors  and  is  approximately  80-100  times 
potent as morphine. It has a rapid onset action and shorter duration of action.The peak 
analgesic effect occurs within 5 minutes and the duration of effect is about 30 minutes 
after 1 mcg/kg administered intravenously. Fentanyl is principally bound to albumin which 
favors  its  transplacental  transfer.  For  analgesia  in  labour  50-100mcg/hour  is  required, 
given in increments of 10mcg IV.
REGIONAL
Lumbar epidural block
Caudal epidural block
Sub arachnoid block
Combined spinal-epidural
Lumbar sympathetic block
Paracervical block
Pudendal block
INHALATIONAL AGENTS
Several  inhalational  agents,  both  gaseous  and  volatile,  have  been  used  successfully  in 
labour.  The  earliest  to  be  used  were  ether,  chloroform  and  cyclopropane,  followed  by 
trichloroethylene and methoxyflurane.Enflurane, isoflurane and desflurane are more recent 
additions.Analgesia during labour can be provided by the inhalational  anaesthetic agents in 
subanaesthetic concentrations thus relieving pain whilst maintaining maternal consciousness 
and avoiding regurgitation or aspiration of stomach contents. In fact, the competence of the 
upper oesophageal sphincter is well maintained under light general anaesthesia, although lost 
under  mild  sedation  with  barbiturate  or  diazepam.  Inhalational  agents  readily cross  the 
placenta and the concentration in foetal blood soon approaches that of the mother but, since 
these agents are excreted almost entirely through the lungs, they are readily excreted from 
the newborn.The efficacy of inhalational analgesia depends on the analgesic strength of  the 
agent and on how quickly it reaches analgesic concentration after the start of inspiration.A 
rapid offset  with  complete  elimination  between  contractions  would prevent   accumulation 
completely. 
Nitrous oxide is  the best  match in  current  use.Various portable  machines exist  for 
administration of nitrous oxide blended with oxygen through an on-demand valve. 
Nitrous oxide concentrations can be varied from 0 to 75% in oxygen. For self-administration, a 
concentration above 50% nitrous oxide should not be allowed.  Entonox, which is a mixture of 
50% nitrous oxide and 50% oxygen is most commonly used. Nitrous oxide does not interfere 
with uterine  activity (1) 
Ether has  several  side  effects  including  potent  emetic  effects  with  an   unpleasant 
pungent odour, irritant to the respiratory tract and explosive.Chloroform has a pleasant odour, 
is non-irritant, more potent and faster acting than ether but has undesirable, dose-related side 
effects, namely arrhythmias and liver damage.
Methoxyflurane and trichloroethyline have been used for analgesia in 
labour, but have been withdrawn for other, nonobstetric, reasons.
Enflurane and isoflurane have been given via a draw-over vaporiser in sub anaesthetic 
concentrations to relieve pain in labour. The usual concentrations, in oxygen, of enflurane and 
isoflurane for self administration are 0.3-1% and 0.2-0.7%. 
Such concentrations will not change uterine contractility or responsiveness to oxytocin. 
The neonate is not affected by these analgesic concentrations of these inhalational agents. 
Enflurane, however, causes long- term drowsiness so was never popular.Both the agents are 
expensive  and  since  neither  shows  a  significant  advantage  over  entonox  in  terms  of 
analgesia they are unlikely to be widely used on their own.
Desflurane is the newest volatile agent to be applied in labour. The chief advantage of 
this agent is rapid onset and offset of action, however it is expensive and since it has not 
been shown to provide superior analgesia to entonox, it is unlikely to become a popular agent 
for labour analgesia
EPIDURAL SPACE-ANATOMY AND CHANGES IN PREGNANCY
The epidural space is the interval between periosteum lining the vertebral canal and the 
dura mater surrounding the canal in its extension from foramen magnum to lower end of dural 
sac
.Boundaries:
Superiorly :    foramen magnum
Inferiorly :      Sacro coccygeal membrane
Anteriorly       :     Posterior longitudinal ligament covering vertebral bodies and discs
Posteriorly :  Anterior surfaces of laminae connecting Ligaments,roots of 
spines ligamentum flavum.
Laterally :     pedicles and inter vertebral foramina 
Contents:
• Dural sac
• Spinal nerve roots
• extra dural plexus of veins
• spinal arteries
• lymphatics and fat
Size:
Anterior portion  - 1mm  (through out the length)
posterolateral    -at cervical leve  1.5-2mm
- at thoracic level3-5mm
- at lumbar level 4-6mm
Changes in pregnancy
• the lumbar lordosis associated with pregnancy increases the technical 
difficulty in performing epidural or sub arachnoid puncture when midline method is 
carried out
• increased  elastic  tissue  and  softening  of  connective  tissue  and 
increased water content leads to difficulty in identification of epidural space by loss 
of resistance.
• Intermittent obstruction of IVC by enlarged uterus encourages venous 
drainage through alternate pathways and so the vertebral or azygos system dilate 
the epidural internal vertebral venous plexus which reduces the internal volume of 
the epidural space. Hence segmental doses are reduced in pregnancy.
• During contractions sudden efflux of blood from contracting uterus into 
the venous system increases the epidural pressure so the spread of anaesthetic 
solution in the epidural space will be exaggerated during a contraction so injection 
should not be made at this time. The risk of venous puncture by needle or catheter 
will  be increased if  either is inserted into the epidural  space during contraction 
because of engorged vertebral plexus. In the non pregnant state the pressure in 
the  lumbar  epidural  space  is  normally  -1cm  H2O.  In  early  labor  between 
contractions pressure in the lateral  position average 1.63 cm h20 and raise to 
4-10cm H2O by the end of first stage of labor during contraction. Assuming  the 
supine position will  increases the epidural  pressure further proportional  ton the 
degree of IVC obstruction so there is a positive pressure inside the epidural space 
in  pregnancy.  Hence  methods  for  identifying  the  space  which  depend  on  the 
presence of negative pressure are not recommended.
ENTONOX
Entonox is the 50-50 mixture of nitrous oxide (N20) and Oxygen (02). It is a
effective analgesic agent with rapid onset and offset characteristics. Due to the
extensive experience in the use of Entonox and N20, its effects are predictable 
and reliable and it has proved to be a very safe agent with minimal side effects
HISTORY
Nitrous oxide was discovered and purified by Priestley, Mayow and Hales in the 
mid 1700’s and in the late 1700’s was used extensively due to its pleasurable 
effects.The American dentist Horace Wells first used it medically in 1844 to 
reduce the pain of tooth extraction. The first report of the use of nitrous oxide for 
the relief of labour pain appeared in 1880 in the St Petersburg Medical Weekly. In 
that publication, and in subsequent reports. Klikovich (or Klikowitsch) described 
his use of a mixture of 80% nitrous oxide and 20% oxygen in obstetric 
patientsDuring the late 1800’s the use of N20 became popular in the USA and 
was introduced into Europe, in 1867, by quincy and coulton.Interestingly, until the 
late 1800’s nitrous oxide was used alone  and without any supplemental air or 
oxygen, therefore some of the sedative and  analgesic effects of the gas could 
have been due to hypoxia. 
In 1881 N20 was introduced for pain relief in childbirth and in  1911 Guedel 
described an analgesic technique (possibly the first patient controlled analgesia) 
in which the patients self- administered a mixture of air and N20 during childbirth 
and minor surgery. 
BOC studied the N20/02 system after a suggestion from Tunstall in 1961 ( 8 ). It 
was found that it was possible to store a homogeneous gas mixture containing up 
THE ENTONOX ADMINISTRATION KIT
to  about 75% N20 at a pressure of 132 bar at ambient temperature, (pure N20 
liquefies at 50 bar at ambient temperature). Since the Introduction of Entonox into 
obstetric practice by Tunstall in I96l and into the ambulance service by Baskett in 
I 970, Entonox has become the mainstay of analgesia for childbirth and pain relief 
in acute situations in many countries.

Today N20 is an essential ingredient in anaesthesia.As Entonox, it is a vital part 
of analgesia for childbirth and is uniquely placed as an ideal agent for the 
treatment of short-term pain due to almost any cause
PROPERTIES
Nitrous oxide is a low-molecular-weight, odorless to sweet-smelling 
nonflammable gas of low potency and poor blood solubility. Although nitrous 
oxide is nonflamrnable,it will support combustion Its poor blood solubility,permits, 
rapid achievement of an alveolar and brain partial pressure of the drug (see Fig. 
1-17). The analgesic effect of nitrous oxide are prominent, but it causes minimal 
skeletal muscle relaxation.
Physical and chemical properties
Molecular weight 44
Blood gas partition coefficient 0.46
MAC 104
ENTONOX CYLINDERS
SHOWING THE PIN INDEX SYSTEM OF 7 CYLINDER CONNECTED AND READY TO USE 

Entonox is a gaseous analgesic agent that is composed of N20 and 02 in equal proportions. It 
is presented in cylinders that are painted blue with a white and blue shoulder.
Highest -5.5°C 117 bar  Cylinder -7°C 137 bar  Pipeline -30°C 4 bar
Storage
Entonox is stored in white or blue cylinders with blue and white shoulders with PIN INDEX of 
7.  It is supplied in cylinders at a pressure of 137 bar and must be stored above its pseudo 
critical temperature of -6°C.  Below this temperature the N2O liquefies in a process called 
lamination.  If this occurs a high concentration of O2 will be delivered first with little analgesic 
effect, but as the cylinder empties the mixture will become progressively more potent and 
hypoxic as it approaches 100% N2O. If a cylinder has been exposed to cold below -6 degree 
C it should be warmed for 5 minutes in a 37 degree C water bath or for 2 hours in a room at 
15 degree C. It should then be inverted three times before use.
When delivered via a pipeline at 4.1 bar the pseudocritical temperature is less than -30°C. In 
the large cylinders used for connection to a pipeline system via a manifold, gas is therefore 
drawn first from the bottom of the cylinder by a tube
Poynting effect
The Poynting effect involves the dissolution of gaseous O2 when bubbled through liquid N2O, 
with vaporisation of the liquid to form a gaseous O2/N2O mixture.
[Poynting, John Henry (1852-1914).  English physicist, mathematician, and inventor.]
Pseudocritical temperature
The critical temperature of a gas is the maximum temperature at which compression can 
cause liquefaction. Mixing gases may change their critical temperature. The Poynting effect 
produces a 50:50 mixture which reduces the critical temperature of N20 so Entonox has a 
pseudocritical temperature of -6oC.
The gas is contained at a pressure of 137 bar and is delivered to the patient by 
using a pressure regulator and demand valve. The patient will self- administers 
the gas, under the supervision of an appropriate healthcare professional, by 
using a facemask or mouthpiece. Entonox is widely used as an analgesic agent 
but its mechanism of action has not yet been fully explained. It is known that the 
effects of Entonox take place within the pain centres of the brain and spinal cord 
and are related to the release of endogenous neurotransmitters such as opioid 
peptides and serotonin, and activation of certain opioid receptors. Also, Jevtovic-
todorovic et al(9) found that N-methyl-D-aspartate (NMDA) receptor currents 
were inhibited by N20, and it is known that the NMDA receptor is involved in 
many CNS pathways that control sensations, such as pain and euphoria. Whilst 
many of the anaesthetic mechanism of N20 remain unknown, there is increasing 
clarity as to the analgesic effects of this gas. A recent hypothesis suggests that 
Entonox has its analgesic effects by the activation of descending noradrenergic 
pathways due to release of opioid peptides in the peri-aqueductal grey area of 
the midbrain. These descending pathways are thought to modulate pain through 
the activation of alpha-2 adreno- receptors in the dorsal horn of the spinal cord. 
Due to the physical properties of N20 (namely its blood/gas solubility) Entonox
works very quickly and analgesia is maximal within 2 minutes of inhaling the gas 
but its effects are apparent within a matter of breaths. 
Recovery from the effects of N20 is very rapid. Once inhalation of Entonox has
stopped, there is fall of 35% in the arterial concentration within 30 seconds. 
Studies have shown a subjective feeling of complete recovery, within 5 minutes, 
in individuals who breathed 40% N20 for 30 minutes.
Although a relatively lipid insoluble inhalational agent, nitrous oxide needs to he
inhaled for 45 seconds before the maximum analgesic effect can be obtained , 
SO during the first stage, inhalation should be commenced at the first warning of 
a contraction and not delayed until pain appears. For optimum effect inhalation 
should start when the contraction tightens to co-ordinate the maximal effect with 
the central painful part of the contraction. Should unconsciousness occur, the 
patient drops the mask and recovery rapidly occurs Once inhalation ceases, 
blood alveolar concentrations decline rapidly and the analgesic effect is very 
short lived. Pain dominates the whole of a second stage contraction and no 
warning is perceived by the mother. dependence should be placed on the 
regularity of second stage contractions, and inhalation commenced at least 30 
seconds before the next expected contraction. When the mother is bearing down 
late in the second stage she should quickly inhale 4 to  times from the  machine, 
hold her breath and then push. The maneuver can be repeated if the analgesia 
wears off before the contraction is completed. 
When used correctly, Entonox can be surprisingly effective. There are minimal
cardiovascular, respiratory or neurological side effects. With the intermittent 
inhalation of nitrous oxide, nitrous oxide does not depress neonatal respiration or 
affect neonatal neurobehavior. ( 7 ) It should not be used in patients with a 
pneumothorax
SELF ADMINISTRATION OF ENTONOX BY A PATIENT
Due to the low fat solubility of N2O, it does not accumulate to any great extent 
within the body and in addition N20 is not metabolized by the body and will be 
eliminated completely by the lungs. ( 6 )
The pharmacological profile of Entonox offers rapid onset of potent analgesia 
with speedy reversal of effects when required.This fast offset of action offers a 
clear advantage over all other analgesic agents, and if used in combination for 
pain relief allows a reduction in the doses of the other agents used (e.g. 
morphine, pethidine), thus reducing the often serious side effects associated with 
them.
Contraindications to Nitrous Oxide
N2O should not be used for patients with bowel obstruction, pneumothorax, middle ear and 
sinus disease, and following cerebral air-contrast studies. Many anesthetists feel that use of 
N2O should be restricted during the first two trimesters of pregnancy because of its effects on 
DNA production and the experimental and epidemiological evidence that N2O causes 
undesirable reproductive outcomes. Since N2O affects white blood cell production and 
function, it has been recommended that N2O not be administered to immunosuppressed 
patients or to patients requiring multiple general anaesthetics.
Cardio-vascular system 
Entonox has minor effects on the heart and circulation. In its use in general
anaesthesia, N20 is known to have a slight direct myocardial depressant effect
together with a weak stimulatory effect on the sympathetic system. The net effect is an 
unchanged or a very slightly decreased cardiac output, blood pressure and
systemic vascular resistance. The general opinion of the literature is that Entonox
has only a slight effect on cardlo-vascular parameters and is safe in patients with
heart disease, even those who are hypovolaemic. 
Respiratory system 
The effect of Entonox on respiration are minimal. There is a small decrease in 
tidal volume that is compensated for by a small increase in respiratory rate. The
combined effect of these changes is often a slight increase in minute ventilation
without a change in blood carbon dioxide (CO2) levels. 
Diffusion hypoxia is a phenomenon that can occur after inhaling N20 during
anaesthesia. It is due to N20 diffusing out of the body faster than nitrogen can
diffuse in, thus resulting in dilution of the 02 contained within the lungs and a
reduction in arterial oxygen levels and saturation(5 )
Gastro-intestinal system 
The safety of Entonox in gastro-intestinal procedures has been shown. There 
were no significant alteration in bowel function
Nausea and vomiting
Nitrous oxide, when used in anaesthesia, may cause a weak emetic effect in 
certain individuals.
Enclosed gas spaces 
The use of Entonox is contra-indicated in some cases where there is trapped air
within the body, because N20 will diffuse rapidly into the space, thus increasing 
its size. 
The contra-indications include: 
• Artificial, traumatic or spontaneous pneumothorax • Intestinal obstruction 
• Air embolism • Decompression sickness • Head injuries with impaired
consciousness .Myringoplasty • Recent underwater dive Intoxication • Following 
air encephalography • Maxillofacial injuries  • Severe bullous emphysema 
• Patient non-compliance 
Effects on vitamin synthesis 
The N20 component of Entonox can effect vitamin B12 synthesis by inhibiting the
enzyme methionine synthetase. The effect may be of importance if the 
therapeutic exposure to Entonox exceeds 6-8 hours. If exposure of Entonox is 
greater than 6 hours N20 can also interfere with folate metabolism and DNA 
synthesis, which can impair bone marrow function But Nunn et al  reported that 
evidence of actual harm to patients is lacking unless in extreme circumstances 
and stressed that the effects on vitamin B12 and folate require prolonged 
exposure.
Occupational exposure to Entonox ( 2 ) ( 3) (4  )
Long term occupational exposure to significant levels of N20 can result in
Myeloneuropathy — a condition similar to sub-acute combined degeneration of 
the spinal cord, in which there is peripheral sensory and motor impairment. This
condition has been reported in individuals addicted to the inhalation of Entonox 
and N20. There has also been concern that N20 exposure can lead to 
spontaneous abortion. This idea is based on work done on pregnant rats that 
were exposed to high levels of N20 for prolonged periods. There has been very 
little evidence that similar effects occur on humans, but a questionnaire by 
Rowland et a15’ suggested a slightly higher risk of abortion in dental nurses 
working in rooms without scavenging. Alternatively, a study involving almost 4000 
midwives stated that the use of N20/02 is not associated with an increased risk of 
abortion. In order to reduce the risks to staff the Health and Safety committee has 
set an occupational exposure limit of lOO ppm over an 8-hour Period. This is a 
fifth of the dose at which no effects were seen in animal studies and represents a 
level at which there is no evidence that human health would be affected. A study 
by Henderson et a! in 1999 showed that over a 14 month period, in the 
anaesthetic rooms, operating theatres and recovery rooms of 8 hospitals within 
Wales, the time weighted average levels all fell within the
occupational exposure limit. The same standards apply to maternity units and 
dental practices where Entonox is used commonly, but these areas can often 
have raised exposure levels due to lack of effective ventilation and gas 
scavenging systems. 
Environmental pollution 
Nitrous oxide has little effect on the ozone layer, but does have a minor influence 
on the green house effect since it reduces heat radiation. However, the energy 
information administration (USA) states the principle source of N20 is the 
breakdown of fertilisers and natural compounds in the soil. Medical N20 
contributes only 0.5% of the total release of N20 in to the atmosphere in the USA. 
Nitrous oxide and Entonox have been used in pain relief, sedation and 
anaesthesia for more than 150 years.Millions, perhaps billions, of patients have 
been treated without any serious sideeffects or adverse events having been 
reported. 
The effects of Entonox are fast. They are felt after only three or four breaths and 
are maximal after just 2 minutes. The effects also disappear rapidly once Entonox 
is removed and even with sensitive psychometric tests, it is difficult to display 
residua leffects after 30-40 minutes. 
Great strides have been made in the pre-hospital, emergency and hospital
management of patients, yet the relief of pain and suffering is something that is
often forgotten, or provided in a sub-optimal fashion. In addition, it is easy not to
appreciate the pain the patient has or to overlook it as it is produced whilst one is
seeking to help.
OPIATES
"God's Own Medicine"
Sir William Osler
Opioids refer to all exogenous substances natural and synthetic that binds specifically to any 
of the several sub population of opioid receptors. Opioid receptors were discovered by  PERT 
and SNYDER in 1974
Mode of action of opioids
Opioid receptors are presynaptic. Activation of Gi proteins leads to inhibition by increased K+ 
conductance  and  hyperpolarisation  of  the  cell  membrane.  The  decrease  in  membrane 
excitability may decrease pre- and post-synaptic responses.
Opioid receptors
The existence of multiple opioid receptor subtypes arose from work identifying the different 
anatomical location and pharmacological profiles of compounds that were eventually used to 
name them: 
• morphine (mu) 
• ketocyclazocine (kappa) 
• vas deferens (delta)
• A fourth opioid-like receptor has been included in the opioid receptor family and is 
termed the nociceptin orphanin FQ peptide receptor. 
Sigma is not considered to be an opioid receptor, since responses induced by 
activation of this receptor are not reversed by naloxone. 
International Union of Pharmacology (IUPHAR) 
This body have declared that the new accepted nomenclature for opiod receptors is: 
• MOP (mu)
• KOP (kappa) 
• DOP (delta) 
• NOP (nociceptin orphanin FQ peptide receptor) 
Opioid receptor subtypes
MOP
The MOP receptor was the last of the classical opioid receptors to be cloned and is located 
throughout  the  central  nervous  system  in  areas  involved  in  sensory  andmotor  function 
including regions concerned with the integration and perception of these senses, for example 
the  cerebral  cortex  and  amygdala  .  
A high density of MOP receptors is found in the caudate putamen of the basal ganglia. MOP 
receptors are located pre-synaptically on primary afferent neurons within the dorsal horn of 
the spinal cord where they inhibit glutamate release and hence transmission of nociceptive 
stimuli from C and A-delta fibres. The periaqueductal grey (PAG) is an area of the midbrain 
involved in the central  control  of  nociceptive transmission.  Efferent outflow from the PAG 
descends to the spinal cord where it acts to inhibit nociceptive transmission in afferent fibres, 
this pathway is known as the descending inhibitory control pathway. High densities of MOP 
receptors are found in the PAG and the analgesia of some opioids may come about from 
removal of an inhibitory gamma-amino butyric acid (GABA)-ergic tone in this region of the 
brain.  GABA is the main inhibitory transmitter  in the brain and acts  to  reduce or prevent 
antinociceptive outflow from the PAG. 
Major side-effects associated with MOP agonists include respiratory depression through a 
reduction in the sensitivity of central and peripheral chemoreceptors to hypercapnia. MOP 
agonists  further  inhibit  gastrointestinal  tract  secretions  and  peristalsis,  often  causing 
constipation. MOP opioids also have effects on the cardiovascular system, thermoregulation, 
hormone secretion and immune function.
DOP (Delta)
The DOP receptor was the first to be cloned and is less widely distributed relative to the other 
opioid  receptors.  The  highest  densities  are  found  in  the  olfactory  bulb,  cerebral  cortex, 
nucleus accumbens and the caudate putamen. DOP receptors are located pre-synaptically on 
primary afferents where they inhibit the release of neurotransmitters. 
Through  both  spinal  and  supraspinal  sites,  the  receptor  is  involved  in  the 
antinociceptive/analgesic  actions of  some opioids.  However,  DOP receptor  agonists  have 
also been shown to reduce gastrointestinal tract motility and cause respiratory depression.
KOP (Kappa)
The kappa or KOP receptor was the second of the opioid receptor family to be cloned. The 
prototypical agonist of the kappa receptor is the non-peptide benzomorphan ketocyclazocine, 
the actions of which have been shown to be distinct from those elicited by stimulation of the 
MOP receptor, for example sedation without marked effects on heart rate. 
NOP
At the cellular level, N/OFQ produces similar actions to those of the classical opioids resulting 
in reduced neuronal excitability and inhibition of transmitter release.  However, exogenous 
administration has been shown to have effects on locomotion,  stress and anxiety, feeding, 
learning and memory, reward/addiction and urogenital activity. 
PHARMACOLOGY OF FENTANYL
FENTANYL CITRATE is a synthetic phenyl piperidine derivative MOP  2 receptor agonist 
It is a chemical congener of reversed ester of pethidine
80-100 times as potent as morphine
Pharmacodynamics:
Respiratory system:
• Dose dependant respiratory depression through direct action on medullar respiratory 
centers.
• Apneic threshold increased
• Hypoxic drive reduced
• Chest wall rigidity-anti tussive action
• Delayed respiratory depression
Cardiovascular system:
• Bradycardia – due to central vagal stimulation in high doses
• No effect in cardiac contractility
• Hypotension especially in large doses due to bradycardia, venodilatation, suppression 
of central sympathetic outflow.
Central Nervous System
• Analgesia
• Euphoria
• Sedation/hypnosis
• Miosis
• Nausea /vomiting
GIT
• Delays gastric emptying
• Biliary spasm
Endocrine System
• Attenuation of stress response
Pharmacokinetics:
It has rapid onset of action less than 30 secs when given as a single intravenous dose 
Highly lipid soluble and rapid redistribution
Lungs act as a large reservoir  with 75%of the initial dose undergoing first pulmonary uptake.
Metabolism
Is by liver and undergoes N – dealkylation, hydroxylation,and amide hydrolysis to inactive 
metabolites namely norfentanyl and des propinyl nor fentanyl and excreted via bile
• Percentage bound to plasma proteins  84%
• t1/2                  1-2 min
Epidural fentanyl
Clinical properties Advantages Disadvantages
Rapid onset Rapid analgesia Systemic absorption
Short duration Decreased side effects Brief single dose 
analgesia
Low CSF solubility Ideal for continuous
infusion
Minimal CSF spread
Since 1980 fentanyl is used for epidural analgesia
• Dose  50-200 mcg
• Onset  5-15 mins
• Duration 2-4 hours after single dose
When given intra-thecal these opioids should be injected as close as possible to the spinal 
segment where primary nociceptic afferent carrying the nociceptive impulse from involved 
dermatomes enter the spinal cord. When this is accomplished small dose of the drug will 
produce significant analgesia.
Effect On labor:
1. If given during the latent phase of the first stage of labor there   is tendency for it to 
slow cervical dilatation and it may even result in uterine inertia.
2. Optimum dose has no significant depressant effect while an    excessive dose delays 
labor.
Effect on fetus:
1. Direct effect after absorption depresses the fetus.
2. Indirect effect occurs if given in large doses through effects on maternal circulation and 
respiration
Side Effects:
• Pruritus
• Sedation
• Urinary retention
• Nausea
• Vomiting
• Apnea
• Seizures
Factors associated with respiratory depression:
• Poor general condition
• Elderly patients
• Hydrophilic opioids
• Concomitant use of other drugs
Over dosage:
1. Apnea / Hypo-ventilation Oxygen Administration
maintain airway
Endotracheal intubation
Assist respiration
2. depressed respiration intra venous
With muscular  rigidity neuromuscular
blocking agents required to
Assist or control respiration
3. Hypotension parenteral fluids
4. Respiration depression nalorphine, Levellorphan,
Naloxone
PHARMACOLOGY OF BUPIVACAINE
It is an amide linked local anaesthetic. Synthesized by .A.F.Ekensham and introduced into 
clinical practice by Telivuo in 1963.
STRUCTURE
It is an amino amide local anaesthetic having aromatic moiety (benzene ring) which 
offers lipophilicity at one end of molecules linked by an amide to a tertiary amine which is 
hydrophilic on the other end of the molecule.
MOLECULAR FORMULA
It displays stereoisomerism; marketed as a racemic mixture containing optically active 
enantiomers R and S .S enantiomer has been noted to have a slightly longer duration of 
action yet lower systemic toxicity when compared to its R type.
MECHANISM OF ACTION:
The  base  form  is  in  equilibrium,  with  the  cationic  form  out  side  the  axoplasmic 
membrane. The base form diffuse inside in the cell  and then equilibrates with the cationic 
form  which  reaches  the  local  anaesthetic  receptor  on  the  sodium channel  by  traversing 
channel pores while it is in the open state preventing sodium ions movement intracellular.
The second messengers system is also affected  where the Adenylate cyclase and 
guanylate cyclase are involved and inhibition of synaptic transmission occurs. This may be 
due to presynaptic calcium channel blockade or post synaptic receptor modification
PHYSICOCHEMICAL CHARACTERISTICS
Molecular weight     288
Potency ratio 15
Toxicity ratio 10
pka 8.16
protein binding
maternal 95
fetal 66
partition coefficient 346
PHARMACOKINETICS OF EPIDURAL BUPIVACAINE
The uptake of  local  anesthetics  into  blood vessels  in  the  area where  it  has  been 
deposited and its  subsequent  transfer  into  systemic circulation is  generally defined to  as 
systemic absorption.
Absorption
A  biphasic absorption pattern has been found for epidural bupivacaine the rapid initial 
absorption  following  epidural  administration  is  most  likely  related  to  high  concentration 
gradient between drug on the solution and in the blood. Later on after the local anesthetic has 
been taken up into local tissues such as epidural fat absorption will become dependent on 
tissue blood partitioning resulting in slow absorption. With mean absorption time 8.6 hours. 
Bupivacaine will produce lower C MAX than less potent and less lipid soluble agents.
Distribution
Has some special emphasis on the pregnant patient, because one of the organs that 
will be exposed to absorbed drug is the fetoplacental unit.
Pharmacokinetics:
T1/2 162 MIN
Vdss  73 lits
Clearance  .6 lit/min
Metabolism and elimination
Liver  is  a  major  site  of  metabolism.  There  are  two  major  factors  controlling  the 
clearance of the amide-linked local anesthetic. They are hepatic blood flow and the blood 
function. The principal pathways of metabolism are N-Dealkylation. Aromatic hydroxylation 
and amide hydrolysis.
Factors affecting placental transfer of local anesthetics.
1. C Max
2. Utero-placental perfusion
3. Fetal disposition.
4. Feto-maternal ratio
Fetomaternal ratio refers to the amount of total drug that equilibrates between the fetus 
and the mother and includes the protein bound drug. The F/M ratio for bupivacaine is 0.3-4.4. 
However it is the unbound form that rapidly equilibrates across the placenta and with other 
compartment in the foetus. Hence if the maternal levels of drug are dangerously high, then 
the foetus will be exposed to similar concentration. For drugs that are highly protein bound 
such as bupivacaine the F/M ratio is of little clinical significance. The Half-life of bupivacaine 
in newborn is 8.1 hours and plasma protein binding is 66%. Bupivacaine appears to be safer 
in view of high protein binding, high PKA, and low F/M ratio.
CLINICAL CHARACTERSTICS
Penetrance Moderate
Duration 6-8 Hrs
Infiltration 0.05 %
Field Block 0.1%
Pudendal/Para-cervical block 0.125%
Extra-dural Block
For analgesia
For motor block
0.125%-0.25%
0.5%-0.75%
Toxic dose 2mg per Kg
Adverse effects and complications of local anesthesics
CNS toxicity
Potentially toxic blood level can occur if the drug is injected intra-venous and intra-arterially or 
if a large dose of drug is injected into a highly vascular area. Risk of CNS toxicity is more is 
because  bupivacaine  is  highly  protein  bound  drug.  Pregnancy  is  associated  with  30% 
reduction in protein binding which allows for higher brain levels of bupivacaine for a given 
dose of drug.
Symptoms
Slow speech, jerky movements, tremors, hallucinations, seizures. 
Treatment
• Adequate ventilation with 100% oxygen
• Protection of airway
• Suppression of seizure activity (thiopentone 50-100mg/ midazolam 1-2 mg IV)
• Paralysis and endotracheal incubation
Cardio- vascular system
• Dose dependent, depression of contractility, dose dependant, depression of 
conduction in all conduction tissues.
• Progressive prolongation of ventricular conduction time.
• Predisposition to re-entry phenomenon followed by sudden onset of ventricular 
fibrillation.4 times more potent than lignocaine
Treatment
If cardio-vascular collapse occurs
• Start CPCR
• Endotracheal incubation at the earliest
• Vigorous fluid resuscitation
• To improve venous return
• Leg elevation
• Left uterine displacement
• Delivery of foetus
• Adrenaline
• Bretylium for tachyarrhythmias
REVIEW OF LITERATURE:
Harrison RF et al 1987
Conducted A comparative study of transcutaneous electrical nerve stimulation (TENS), 
entonox, pethidine + promazine and lumbar epidural for pain relief in labor. Analgesic effect, 
labor outcome, safety and patient satisfaction were compared in 170 primigravid women; 50 
using TENS initially for pain relief, 20 using entonox, 50 pethidine + promazine and 50 lumbar 
epidural.  88% choosing  epidural  related  it  fully  effective.  90% using  entonox,  96% using 
TENS and 54% given pethidine + promazine found partial relief. 82% of patients given TENS 
and 80% given pethidine + promazine required additional analgesia. This was also needed by 
one of the 20 patients choosing entonox. 
Women  using  entonox  alone  had  the  shortest  labors  and  women  using  lumbar 
epidural, the longest. Operative delivery was significantly more common in women receiving 
lumbar epidural. No significant inter-group differences were noted in cord pH or Apgar scores. 
Parturients And midwives both gave high consumer satisfaction ratings to all methods--except 
for pethidine + promazine, whose use must therefore be questioned. The analgesic efficacy of 
lumbar epidural outweighs any possible side effects. Entonox appears suited to those able to 
cope with the earlier part of labor, drug-free.
Realization of the potential of TENS requires the design of machines specifically to 
cope with the quality of the labor.
Wang B et al  1994  
Labor  analgesia  with  nitrous  oxide  was  studied  in  34  parturients,  and  another  50 
women  taking  no  drug  as  the  control  group.  The  analgesic  effect  was  satisfactory.  By 
Mulleetr's pain in labor score, 91.18% women had score of 0-1, and their respiratory and 
circulatory functions were not affected. During inhalational analgesia the parturients remained 
conscious.  Uterine  contraction,  progress  of  labor  and  neonatal  Apgar  score  were  not 
interferred, and postpartum bleeding was not increased. There was no complications in the 
treatment group. This study suggests that nitrous oxide with enough oxygen inhalation is one 
of the good drug for obstetric analgesia, but its concentration must be strictly controlled.
Su F et al 2002
A total of 1300 cases of term primiparous women in labor were divided into two groups. Study 
group (n = 658) 50% nitrous oxide in oxygen was inhaled during labor for relieving labor pain. 
Control group (n = 642) intermittent inhalation of 50% oxygen was carried out during labor. 
Two  groups  were  compared  with  following  indices:  duration  of  the  labor,  delivery  mode, 
meconium stained of amniotic fluid, postpartum bleeding volume, neonatal Apgar score, side 
effect of nitrous oxide, and blood gas analysis of samples from maternal radius artery and 
fetal  umbilical  blood. RESULTS: The efficiency of relieving labor pain in study group was 
much better than that of control group (80.9% vs 0.9%, P < 0.001). Rate of cesarean section 
in study group was lower than control group (11.6% vs 19.3%, P < 0.05). The active phase of 
labor in study group was shorter than control group (153 min vs 187 min, P < 0.05). There 
was side effect of dizziness in 39.4% cases of study group but there were no any complaint in 
the  control  group cases.  There  were no  significantly differences in  duration  of  the labor, 
meconium stained amniotic fluid, postpartum bleeding volume, neonatal  Apgar score, and 
blood gas analysis between two groups (P > 0.05).  CONCLUSION: Inhalation of 50% nitrous 
oxide in oxygen was safe and effective labor analgesia.  It  is acceptable. The measure of 
relieving labor pain may increase the vaginal birth rate. There is no severe side effect on 
mother and baby.
Ou X et al  2001
A total  of  100 cases of pregnant women were provided with nitrous oxide premixed with 
oxygen  (50%:50%)  (control  group);  Another  100  cases  were  provided  only  with  oxygen 
(comparison  group).  Recording  duration  of  the  Labor,  way  of  delivery,  bleeding  volume, 
Apgars score, blood gas analysis to maternal radius artery and fetal umbilical blood among all 
patients. RESULTS: The effect for analgesia labor of the premixed gas was much better than 
that  of  control  group,  but  there were  no significant  differences in  time of  labor,  bleeding 
volume, Apgars score between the two groups. CONCLUSIONS: The inhalation of nitrous 
oxide  premixed  with  oxygen  (50%:50%)  for  analgesia  labor  benefits  pregnant  women 
because of  keeping  them being  a good mental  and physical  condition.  The inhalation  of 
nitrous oxide for analgesia labor is a safe, effective and easy method.
Hart EM et al 2003
Conducted a retrospective analysis of the obstetric effects of introducing a low-dose epidural 
regimen for epidural analgesia in labour. Before this, all women in this unit requesting epidural 
analgesia for  labour received intermittent boluses (10mL) of 0.25% bupivacaine. After  the 
introduction  of  the  low-dose service  in  March  2000,  intermittent  boluses (10mL)  of  0.1% 
bupivacaine with fentanyl 2 micrograms per ml were given. The groups were compared for 
outcome  of  labour,  quality  of  analgesia  and  any  adverse  events  related  to  the  epidural 
analgesia. There was a significant reduction in the low-dose group in the number of women 
requiring instrumental delivery 41% vs. 29% The need for indwelling bladder catheters was 
also reduced in the patients receiving the low-dose regimen 21.3% vs. 4.7%,. Duration of 
analgesia was longer in patients receiving bupivacaine 0.25% (mean minimum time between 
The need for further anaesthetic intervention was higher with the low-dose regimen 24% vs. 
4Maternal satisfaction was high in both groups (95 and 97%, respectively). We conclude that 
the introduction of a low-dose regimen of epidural analgesia for labour reduces the incidence 
of instrumental deliveries. It also decreases the incidence of bladder catheterisation during 
labour,
Jevtovic-todorovic et al
Found that N-methyl-D-aspartate (NMDA) receptor currents were inhibited by N20, and it is 
known that the NMDA receptor is involved in many CNS pathways that control sensations, 
such  as  pain  and  euphoria.  While  many  of  the  anaesthetic  mechanism  of  N20  remain 
unknown, there is increasing clarity as to the analgesic effects of this gas
Stewart et al 1983
Showed the safety of Entonox in pre-hospital care in a 1983 study of over 1000 patients.They 
found no serious complications, but reported the following minor side effects: 
•  10.3% dizziness •  3.7% excitation     • 5.7% nausea     • 0.3% numbness
7.6% became drowsy or  fell  into  a  light  sleep but  all  could  be  readily roused by verbal 
command, all could cough and swallow on request and no cardiovascular side effects were 
noted. 
Nicola S. Wallace  et al  2003  
Parturients  are  nowadays  encouraged  to  document  their  wishes  for  labor  and  delivery, 
including those for analgesia, in a birth plan. Informed consent is necessary prior to epidural 
insertion, but is difficult  to obtain from a parturient in severe pain, who may already have 
received Entonox or opioid analgesia.
A retrospective survey of 100 random postnatal women. Parturients were interviewed at 24 – 
72 hrs post  partum regarding their  antenatal  wishes for  labor  analgesia,  reasons for  this 
choice,  the  actual  analgesia  received,  what  type of  analgesia  they would  wish  for  future 
labors, what they would advise their friends to use, and their generalised satisfaction. Medical 
notes  were  examined  for  a  previously  documented  birth  plan  and  the  labor  partogram. 
Results: In the antenatal period, 80% of all women had documented a birth plan for labor 
analgesia. Both pharmacological and non pharmacological methods of analgesia were cited. 
For nulliparous patients, the most common reason for antenatal choice of labour analgesia 
was because of friends’ rather than professional advice. Whilst 28% had planned epidural 
analgesia,  72% actually  received  it.  Most  parous  women planned  to  use  what  they  had 
received  in  a  previous  labour  for  analgesia.  44%  planned  whilst  48%  received  epidural 
analgesia. For nulliparous women there was a significant increase in analgesia requirements 
from that planned ( p = 0.039). Parous patients tended to have decreased requirements from 
that planned. 86% of women who changed their mind to request epidural analgesia despite 
no advance planning, did so because they experienced greater pain than they had anticipated 
prenatally. No patient was unhappy that she had received epidural analgesia when she had 
not actively planned this. 98% of those who had received epidural analgesia said that they 
would  request  this  in  subsequent  labours,  compared  with  76%  of  those  who  had  used 
Entonox only and 68% of those who had received Pethidine. The majority would also advise 
their friends to use epidural analgesia.
Conclusions:
1. Most women in labor want epidural analgesia.
2. Women in labor, especially nulliparas, will change their minds.
3. Birth plans for labor analgesia are therefore not predictive.
4. Anesthesiologists should be flexible.
5. Friends are more influential than prenatal classes.
6. Maternal satisfaction with epidural analgesia in labor means that the anesthesiology 
workload in labor ward will increase.
MATERIALS AND METHODS
The Current study was conducted in the Govt. RSRM lying in hospital. Chennai. Forty 
healthy primi parturients aged between 19-25 years were selected for study. The selection 
was purposive and patients with ASA class 1 physical status were taken up.
Institutional approval was obtained..
A prospective randomized trial was conducted. Randomization was done by Third 
party selection marked slips for each patient.
Inclusion criterion;
Primipara
Age 18 to 28 years
Weight 45 to 60 kgs
Height 145 to 165 cms
ASA class I
Cervical dilation 3 - 5 cms
Effacement > 50 percent
Willingness for Epidural
Willingness for Entonox
Able to understand usage of Entonox
Exclusion Criterion
Patient refusal
Multipara
Age, Weight, height parameters outside the range in the inclusion criterion
Any co- morbid condition (Diabetes, PIH, Cardiac disease etc)
Any obstetric complications
Any of the exclusion criterion for Entonox
METHODOLOGY
The patients were counseled at the beginning of the procedure about the Technique 
for which they were randomized. This was to gain the trust of the patients and as for Entonox 
the correct technique for using it was taught to the patient.
Here  some  patients  who  could  not  understand  the  correct  usage  either  due  to 
language  problem  were  excluded  from  the  study.  Consent  was  obtained,  complications 
explained and a brief  physical  status examination was done .all  baseline parameters like 
Heart  rate,  respiratory rate,  Systolic  and Diastolic  Blood Pressure,  FHR,  SPO2,  Baseline 
VAS, were evaluated and recorded.
The patients were explained in detail about the visual analogue score and its usage. All 
doubts were cleared and a baseline VAS was recorded.
ENTONOX GROUP
The patients remained in the labour ward itself. A >15 degree wedge was placed under 
the Right hip. A tablet of Ranitidine 150 mg PO and a Metoclopramide 10 mg  PO with small 
sips of water were given (  33 ). All emergency drugs, equipment were checked and kept 
ready.
All  the  staff  including  Obstetritians,  Paediatritians,  staff  nurses  and  workers  were 
familiarized with the technique both as a way of enlisting their help and to teach them.
Cervical dilation and effacement was measured and if satisfactory the kit given to the 
patient and asked to use as explained to her. The patients were asked to take deep breaths 
of the gas and exhale slowly. They were asked to start using the gas as soon they perceive a 
contraction and not when they feel pain and continue till  the end of contraction. This way 
when they have maximum pain at the peak of contraction they are already under the effect of 
Entonox.To obtain good pain relief the analgesic concentration of N2O in the blood and thus 
the brain at the peak of contraction must be there.
Safety of the intermittent technique depends on the patient using and controlling  the 
breathing  system  without  assistance.  Inhalation  of  Entonox  from  the  standard  breathing 
system is only possible if the patient opens the demand valve attached to the cylinder by 
creating  a  negative  pressure.  Creation  of  the  negative  pressure  is  only  possible  if  the 
facemask is firmly applied to the face, producing an air-tight seal.
If the patient’s level of consciousness is depressed she will be unable to maintain the 
seal, administration of Entonox will cease and the patient will begin to breathe room air. Full 
consciousness will return rapidly (Any attempt by the husband, nurse or doctor to ‘help”the 
mother hold  the mask in  place will  override this safety feature.  The patient  may then be 
anaesthetized and -may regurgitate gastric contents while her airway is unprotected.
SPO2 and pulse rate were monitored throughout using a pulse oxymeter. Progress of 
labour  and  FHR  were  assessed  and  recorded  by  the  obstetrician  Blood  pressure  and 
respiratory  rate  were  recorded  at  regular  intervals.  The  occurrence  of  side  effects  and 
complications were noted.
EPIDURAL GROUP
After the patient accepted epidural analgesia for pain relief, A preanesthetic evaluation 
was performed, which included an assessment of the patient’s medical and anesthetic history. 
The risks of epidural analgesia are discussed with the patient, and informed consent was 
obtained  The obstetrician was consulted to confirm the following  That the patient is in labor 
and the obstetrician is committed to delivering the infant; and that all relevant obstetric issues 
are understood (e.g., gestational age, intrauterine growth restriction, fetal presentation, risk of 
obstetric  hemorrhage,  previous  cesarean  delivery).  An  assessment  of  fetal  well-being  is 
performed in consultation with the obstetrician
The necessary monitors, boyles machine, the emergency drugs and resuscitative kit 
were checked and kept ready in case of necessity.
ADMINISTRATION OF EPIDURAL  ANALGESIA FOR  LABOR: THE  TECHNIQUE
1. Informed consent was obtained, and the obstetrician was consulted. 
2. Monitoring included the following: 
 Blood pressure every 1 to 2 minutes for 15 minutes after giving a bolus of local 
anesthetic; 
Continuous maternal heart rate monitoring during administration of Epidural. 
Continual verbal communication. 
3. The patient was hydrated with 500 mL of Ringer’s lactate solution. ( 19.a ) (19.b  ) 
( 20 ) (21  )
4. The patient assumed a sitting position . Under strict aseptic precaution EPIDURAL 
proceeded with the patient. ( 22 )
5. 17-gauge  Tuohy  needle  used  and  introduced  through  the  L3-L4  inter  space  The 
epidural space was identified with a loss-of-resistance technique. 
6. The epidural catheter (multi orifice) was threaded 4 to 6 cm into the epidural space. 
7. A test dose of 3 mL of 0.25% bupivacaine with 1:200,000 epinephrine was injected 
after  careful  aspiration  and  after  a  uterine  contraction  (to  minimize  the  chance  of 
confusing tachycardia that results from pain with tachycardia as a result of intravenous 
injection of the test dose). (18 )
8. If the test dose was negative,  10mL of 0.125% bupivacaine with 2 micrograms per ml 
fentanyl  was  injected  to  achieve  a  cephalad  sensory  level  of  approximately  T10.’ 
Assessments were made every 2 mins for the first 10 mins and every 5 mins till 30 
mins and then every 30 mins till next top up ( 24 )
9. The  patient  is  cared  for  in  the  lateral  or  semi  lateral  position  to  avoid  aortocaval 
compression ( 23 ) HR, BP, SPO2, FHR was monitored. VAS scale assessed at peak 
of  each  contraction  and  the  time  of  the  establishment  of  epidural  blockade  was 
identified by loss of  pinprick sensation and this  time was noted.  VAS scoring was 
performed at timed intervals after each top up till the end of delivery.Vitals monitored 
and hypotension defined as a decrease of 20%from the base line was treated with 
ephedrine.Sensory level was noted after each top up.
Progress of labor was assessed hourly by the obstetrician. The occurrence of side effects 
or complications was noted This was followed by top up doses of 5 ml of the study solution 
was given on an hourly basis  irrespective of the pain status.If the second stage started after 
30 min of the preceding dose then 5 ml was injected in the sitting position. if  it was less than 
30 min then top up was not given and the vas  score was assessed after 10 min. If the patient 
did not receive adequate pain relief within 30 mins then an additional 5ml of the study solution 
was given and the top up doses were administered 1 hour from then.
Mode of delivery noted and if other than normal the reasons for the intervention noted.
Duration of 1 st stage of labor – time from when patient is handed over to us after noting 
the cervical dilation (Cervical dilatation >3cms Effacement  >50%) to the full dilation of cervix 
noted.
Duration of 2nd stage noted
Fetal and neonatal outcome noted- APGAR scoring was  done at 1 min and 5 min. any 
adverse event in the neonate was recorded.
Finally the overall quality of pain relief was assessed subjective by the post partum 
mother.
OBSERVATION AND RESULTS
Maternal characteristics
0
20
40
AGE IN YEARS
EPIDURAL ENTONOX
EPIDURAL 22.3
ENTONOX 22.7
AGE IN YEARS
SD Epidural Group
COMPARISON OF MEAN AGES
USING UNPAIRED T TEST
P VALUE 0.4705
CONSIDERED NOT SIGNIFICANT
THEY ARE HENCE COMPARABLE
0
20
40
60
WEIGHT IN KGS
EPIDURAL ENTONOX
EPIDURAL 52.15
ENTONOX 50.6
COMPARISON OF MEAN WEIGHTS
USING UNPAIRED T TEST
P VALUE IS 0.2409 
NOT CONSIDERED SIGNIFICANT
THEY ARE HENCE COMPARABLE
120
130
140
150
160
HEIGHT IN CMS
EPIDURAL ENTONOX
EPIDURAL 154.25
ENTONOX 154.95
COMPARISON OF MEAN HEIGHT
USING UNPAIRED T TEST
P VALUE IS 0.6303
NOT CONSIDERED SIGNIFICANT
THEY ARE HENCE COMPARABLE
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GESTATIONAL AGE IN WEEKS
EPIDURAL ENTONOX
EPIDURAL 38.75
ENTONOX 39.1
COMPARISON OF MEAN GESTATIONAL AGE
USING UNPAIRED T TEST
P VALUE IS 0.1851
NOT CONSIDERED SIGNIFICANT
THEY ARE HENCE COMPARABLE
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CERVICAL DILATION WHEN ANALGESIA 
ADMINISTERED (IN CMS)
EPIDURAL ENTONOX
EPIDURAL 3.4
ENTONOX 3.6
COMPARISON OF MEAN CERVICAL DILATION
USING UNPAIRED T TEST
P VALUE IS 0.3841
NOT CONSIDERED SIGNIFICANT
THEY ARE HENCE COMPARABLE
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VAS
EPIDURAL ENTONOX
EPIDURAL 9 7.5 3.45 1.75 0.7 0.75 0.7 0.75 0.9 1.1 1.5 1.2632
ENTONOX 8.95 3.2 3.2 3 2.95 2.95 3 2.9 3.5 5.85 6.25
VAS0 VAS5 VAS10 VAS15 VAS30 VAS45 VAS60 VAS90
VAS12
0
VAS15
0
VAS18
0
VAS24
0
0
5
10
AVERAGE VAS
EPIDURAL ENTONOX
EPIDURAL 0.95805 1.5
ENTONOX 3.15225 7.2
STG.I STG.II
Using Mann Whitney U test
STAGE I    P VALUE IS 0.0001  CONSIDERED SIGNIFICANT
STAGE II   P VALUE IS 0.0001  CONSIDERED SIGNIFICANT
0100
200
DURATION OF LABOUR IN MINUTES
EPIDURAL ENTONOX
EPIDURAL 165.7 48.105 17 248.75
ENTONOX 148.1 37 16.2 191.8
I II III TOTAL 
 
Using unpaired t test
STAGE I    P VALUE IS 0.0001 CONSIDERED SIGNIFICANT
STAGE II   P VALUE IS 0.0001 CONSIDERED SIGNIFICANT
TOTAL DURATION P VALUE IS 0.0001 CONSIDERED SIGNIFICANT
IN EPIDURAL GROUP THE DURATION OF BOTH THE FIRST STAGE AND SECOND 
STAGES ARE PROLONGED.
0
5
10
APGAR
EPIDURAL ENTONOX
EPIDURAL 7.45 9.3
ENTONOX 7.45 9.1
APGAR 1 MIN APGAR 5 MINS
COMPARISON OF AVERAGE APGAR SCORES
Using Mann Whitney U test
APGAR 1 MIN p VALUE IS 0.3823 NOT CONSIDERED SIGNIFICANT
APGAR 5 MIN p VALUE IS 0.1378 NOT CONSIDERED SIGNIFICANT
100
120
140
160
FHR
EPIDURAL ENTONOX
EPIDURAL 128 133 138 136 134 136 137 136 137 136 137 135
ENTONOX 130 133 137 137 137 131 137 133 138 136 138 136
FHR0 FHR5
FHR1
0
FHR1
5
FHR3
0
FHR4
5
FHR6
0
FHR9
0
FHR1
20
FHR1
50
FHR1
80
FHR2
40
50
70
90
110
PULSE RATE
EPIDURAL ENTONOX
EPIDURAL 102.6 100.5 94.65 79.45 80.85 78.95 76.4 80.85 80.25 81.45 79.65 78.45
ENTONOX 103.6 97.3 96.75 96.3 93.4 95.65 88.05 91.95 92.95 103.5 106.4 97
PR0 PR5 PR10 PR15 PR30 PR45 PR60 PR78
PR12
0
PR15
0
PR18
0
PR24
0
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SYSTOLIC BLOOD PRESSURE
EPIDURAL ENTONOX
EPIDURAL 124.8 120.1 115.75 110.7 109.7 112.5 115.15 118.3 113.6 116.3 116.4 116.3
ENTONOX 127.2 117.7 115.15 114.6 117.2 112 119.2 120.9 119.4 127.8 128.1 117.1
SBP0 SBP5 SBP10 SBP15 SBP30 SBP45 SBP60 SBP90
SBP12
0
SBP15
0
SBP18
0
SBP24
0
60
80
100
DIASTOLIC BLOOD PRESSURE
EPIDURAL ENTONOX
EPIDURAL 83.8 80.4 77 73.3 72.7 73.55 74 72.7 73.2 74.7 74.8 74.2
ENTONOX 78.7 79.6 81 79.8 77.8 79.1 76.1 74.7 75.6 84.2 85.3 74.8
DBP 0 DBP5 DBP10 DBP15 DBP30 DBP45 DBP60 DBP90
DBP12
0
DBP15
0
DBP18
0
DBP24
0

75
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95
100
MEAN BLOOD PRESSURE
EPIDURAL ENTONOX
EPIDURAL 97.467 93.633 89.917 85.767 85.033 86.533 87.717 87.9 86.667 88.567 88.667 88.233
ENTONOX 94.867 92.3 92.383 91.4 90.933 90.067 90.467 90.1 90.2 98.733 99.567 88.9
MBP 0 MBP5 MBP 
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MBP 
15
MBP 
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120
MBP 
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TYPE OF DELIVERY
EPIDURAL ENTONOX
EPIDURAL 18 1 1
ENTONOX 19 1 0
NORMAL INSTUMENTAL LSCS
MATERNAL SIDE EFFECTS
Side effects
EPIDURAL ENTONOX
Dural puncture
0 -
Venous puncture
0 -
Pruritus
2 1
Nausea/vomiting
1 4
Rigor
2 0
Sedation 0 17
Hypotension 0 0
Urinary retention 7 0
Resp depression 0 0
Dry mouth 0 8
SENSORY LOSS IN EPIDURAL CASES (AVERAGE)
ONSET OF SENSORY LOSS 9.9 MINUTES
MAX LEVEL T 8.2
Average time for the Patient to Experience pain relief in Entonox Group :44.7 seconds
OVERALL PATIENT SATISFACTION0
20
40
60
80
100
PT. SATISFACTION IN RUPEES
EPIDURAL ENTONOX
EPIDURAL 83
ENTONOX 63
COMPARISON OF MEAN PATIENT SATISFACTION
p VALUE <0.0001
CONSIDERED SIGNIFICANT
SUMMARY OF OBSERVATIONS
      
EPIDURAL ENTONOX
AGE (IN YEARS) 22.8 + 1.83 22.7 + 1.625
WEIGHT (IN KGS) 52.15 + 3.375999 50.6 + 4.739531
HEIGHT (IN CMS) 154.25 + 4.24109 154.95 + 4.860962
GESTATIONAL AGE
(IN WEEKS)
38.75 + 0.786398 39.1 + 0.852242
CERICAL DILATION (IN CMS) 3.4 + 0.680557 3.6 + 0.753937
VAS SCORE I STAGE 0.95805 + 0.245036 3.15225 + 0.429585
VAS SCORE II STAGE 1.5 + 0.492592 7.2 + 0.695852
DURATION OF LABOUR
I STAGE (IN MINS)
165.7 + 11.7029 148.1 + 11.7065
DURATION OF LABOUR
II STAGE (IN MINS)
46.5 + 7.324955 37 + 6.496963
TOTAL DURATION OF 
LABOUR (IN MINS)
248.75 + 15.74894 191.8 + 17.22788
PATIENT SATISFACTION
(IN RUPEES)
83 + 8.645047 63 + 16.88974
DISCUSSION
There exist a number of methods to provide pain relief in the laboring patient from 
psychological to the advanced regional techniques like combined spinal epidurals.
This study sets out to compare the Entonox inhalational technique with a Technique 
that is considered a gold standard for labour analgesia namely Epidural technique.
In this study the concentration of the local anaesthetic was 0.125 percent with 2 ug/ml 
Fentanyl as this low concentration provides very minimal motor blockade.
Blayert  et  al  demonstrated  minimal  motor  blockade  with  the  use of  0.125  percent 
Bupivacaine in his study and confirmed by studies by Meister et al and Dresner et al.
Since  there  is  a  synergy  between  epidural  opioid  and  local  anaesthetic  solutions 
reflecting separate sites of action namely opioid receptors and neuronal axons respectively. 
So, when these two are combined very low concentrations of local anaesthetic and Opioids 
can be used and avoid these side effects of hypotension and drug toxicity- Morgan Clinical 
Anaesthesiology III Edition Pg 826-827.
Effectiveness of Pain relief:
I stage:
The average VAS score for The Epidural Group was 0.958 and for the Entonox group was 
3.152.
II Stage:
The average VAS score for The Epidural Group was 1.5 and for the Entonox group 
was 7.2. Though the patients had lesser pain relief in the Entonox group in the II stage when 
compared to the first stage it must be remembered that the II stage occupies a very small 
duration of the total labour and reasonable pain relief in the I stage is good for the patient. 
Moreover for the patients the II stage passes of in a blur… The patients are distracted by the 
efforts to bear down ,by the constant entreaties by the attending staff to bear down and the 
thrill of seeing the baby emerge. This constant activity in many ways distracts the patient from 
the pain.
Average time for the Patient to Experience pain relief in Entonox Group : 44.7 seconds
Overall Patient Satisfaction:
The Epidural group patients said that the will give an average score of 83 rupees for 
satisfaction and the Entonox group said that they will give 63 rupees.
Harrison RF 1987  ( 26 )  
88% choosing epidural related it fully effective while 90% using Entonox found  partial 
relief. Entonox appears suited to those able to cope with the earlier part of labor, drug-free.
Rosen MA 2002(  27)
Showed that  A systematic  review of  11 RCTs comparing Entonox with  placebo or 
other  inhaled agents showed that  Entonox provided a consistent  but  moderate analgesic 
effect
Benhamou D Et al 2002 (28 )
State that Epidural analgesia is the most efficient technique for labor pain relief
Su F Et al 2002  ( 29 )  
State that:The efficiency of relieving labor pain in study group(Entonox) was much better than 
that of control group(50% O2)
Duration of labour:
I stage
The mean duration in The Epidural group was 165.7 minutes and in the Entonox group 
was 148.1 minutes.
II stage
The mean duration in The Epidural group was 48.1 minutes and in the Entonox group 
was 37 minutes
Overall duration:
The mean duration in The Epidural  group was 248.75 minutes and in the Entonox 
group was 191.8 minutes
Chestnut Obstetric Anaesthesia Pg 369
States:Epidural analgesia during labour is associated with increased risk of  prolonged 
labour.
Kilpatrick and Laros 1989 ( 30 )
Concluded that  the use of  regional  anesthesia  significantly prolonged the first  and 
second stages of labor in both nulliparous and parous women
Thorp et al 1993 ( 14 )
In  their  study  :Randomized  93  nulliparous  women  to  receive  either  epidural 
Bupivacaine  or  intravenous  meperidine  analgesia.  The  mean  ±  standard  deviation  (SD) 
duration of the first stage of labor was 676 ± 394 minutes in the epidural group versus 519 ± 
279 minutes in the meperidine group (P < 0.05).
Sharma et al 2002 (  31 )
State that  :Active phase of  I  stage was 1 hour  longer  in  the epidural  group when 
compared to the meperidine group
Fetal Outcome
The Apgar scores:
1 minute:
The average score for the Epidural group was 7.45 and for the Entonox group was 
7.45 
5 minutes
The average score for the Epidural group was 9.25 and for the Entonox group was  8.9.
The fetal outcomes of both the groups were comparable and differences not significant. All 
the babies in both the groups were well and healthy.
Su F Et al 2002 (  29)
Say that :There were no significantly differences neonatal Apgar score between study 
group  (Entonox)  and that  of  control  group  (50% O2)  .Inhalation  of  50% nitrous  oxide  in 
oxygen was safe .There is no severe side effect on mother and baby
Harrison RF et al 1987  (26  )  
Did A comparative study of transcutaneous electrical nerve stimulation (TENS), entonox, 
pethidine + promazine and lumbar epidural for pain relief in labor  No significant inter-group 
differences were noted in cord pH or Apgar scores.
Stefani SJ 1982 (7  )
Concluded that neither enflurane nor nitrous oxide analgesia adversely affects neonatal 
neurobehavioral status at 15 min, 2 h, or 24 h of age. In their study Neonatal neurobehavioral 
effects of inhalation analgesia for vaginal delivery.
Oxygen saturation:
No  patients  in  both  Epidural  group  or  Entonox  group  had  SPO2  less  than  
95 % in any part of labour.
Su F 2002 ( 29 )
State that : There were no significant differences in the blood gas analysis between two 
groups(study group (Entonox) and that of control group (50% O2))
Carstoniu J et al 1994 (  32 )
Intermittent self-administered 50% nitrous oxide in oxygen does not appear to predispose 
parturient women to hemoglobin oxygen desaturation
Mode of delivery
1 patient in Epidural group and 1 patient in Entonox group were delivered by using outlet 
forceps. The indication was maternal exhaustion. The babies were found to have cord around 
neck .1 patient in the epidural group was delivered by LSCS .
Hemodynamic  parameters like  Pulse  rate  ,Systolic  and  Diastolic  pressures  and 
Respiratory rate were relatively more in the Entonox group than in the Epidural group and 
enen more so in the second stage of labour
Two persons in the Epidural group and 1 person in the Entonox group had pruritus.It was mild 
and only reassurance was needed. No patient in Epidural group had an incidence of dural or 
venous puncture. Four patients in the Entonox group and one patient in the epidural group 
had an incidence of nausea. Two patients in Epidural group had rigors transiently.
Seventeen  patients  with  the  Entonox  group  had  drowsiness  transiently  when  they  were 
inhaling the gas but recovered in 2 to 3 minutes. No patient had an episode of hypotension in 
both groups. Urinary retention occurred in seven patients of Epidural group. Their bladder 
was emptied by simple catheterization. No patient had any episode of respiratory depression.
Eight patients in Entonox group complained of dry mouth which was treated with small sips of 
water.

SUMMARY
In this study the Epidural group offered better pain relief than the Entonox group. The Entonox 
group offered reasonable relief of pain in the first stage though its effectiveness was not good 
in the second stage. 
Duration of labour, both the First stage and the Second stage were prolonged in the Epidural 
group than in the Entonox group. The total duration of labour was hence prolonged in the 
Epidural group. 
Fetal outcome as assessed by the Apgar score at 1 minute and 5 minutes were comparable 
and all the babies were healthy in this study.
There was no appreciable fall  in oxygen saturation in both groups, The incidence of side 
effects like urinary retention was more in the Epidural group and there were more incidence of 
nausea and Dryness of mouth in the Entonox group. Hemodynamics and respiratory rates 
were relatively higher in the Entonox group.
CONCLUSION
In our study we conclude that the Epidural technique offers better pain relief than Entonox 
gas. But it must be remembered that Entonox requires no special skill , easy to use, and safe. 
In many countries it is used by the midwives with one Doctor supervising.
We conclude that Entonox is a good, easy to use alternative to the Epidural technique. It 
can  be  used  in  conditions  were  skilled  help  is  unavailable  and  where  there  may  be 
contraindications to the Epidural Technique.
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PROFORMA
COMPARISON OF ENTONOX WITH EPIDURAL FOR LABOUR ANALGESIA
DATE TIME
ENTONOX EPIDURAL(0.125 % Bupivacaine with 2 μgm/ml Fentanyl
NAME AGE Ht Wt IP NO
GESTATIONAL AGE LMP EDD
UNIT
INITIAL CLINICAL EXAMINATION
CONSIOUS ORIENTED CVS RS
PR BP RR SPO2 TEMP
CERVICAL DILATION EFFACEMENT CONTRACTIONS
VAS PRESENTATION FHR
EPIDURAL:
SPACE…………… SKIN TO EPIDURAL SPACE……..
LENGHTH OF CATHETER IN EPIDURAL SPACE
EPIDURAL DRUG ADM DETAILS
DRUG DOSE/VOLUME WITH TIME:
1.
2.
3.
4.
5.
TIMINGS:
1. SKIN INFILTRATION
2. EPIDURAL CATHETER INSERTION
3. ADM OF DRUG.
4. ONSET OF SENSORY LOSS:
5. I STAGE 
6. II STAGE
7. III STAGE
8. TOTAL DURATION OF SURGERY
9. ONSET OF PAIN RELIEF WITH ENTONOX
OBSTETRIC INTERVENTIONS/COMPLICATIONS
MODE OF DELIVERY:
FETAL OUTCOME APGAR 1 MIN 5 MIN BABY WT
PATIENT FEEDBACK AT THE END OF PROCEDURE (IN RUPEES)
SIDE EFFECTS
DURAL/VASCULAR PUNCTURE NAUSEA/VOMITING PRURITUS
RIGORS RESP.DEPRESSION DRY MOUTH
URINARY RETENTION OTHER
TIME PR SBP DBP RR SPO2 FHR VAS SENS 
BLOCK
OTHER



               



















